SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-222985
Filing Date
2021-07-23
Accepted
2021-07-23 16:02:10
Documents
14
Period of Report
2021-07-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d159893d8k.htm   iXBRL 8-K 23884
2 EX-99.1 d159893dex991.htm EX-99.1 159374
6 GRAPHIC g159893g86x16.jpg GRAPHIC 46370
  Complete submission text file 0001193125-21-222985.txt   415811

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnov-20210720.xsd EX-101.SCH 2898
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20210720_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20210720_pre.xml EX-101.PRE 11412
7 EXTRACTED XBRL INSTANCE DOCUMENT d159893d8k_htm.xml XML 3390
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33185 | Film No.: 211110890
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences